Scientists test new pill formula for epilepsy and Alzheimer's
NCT ID NCT07222878
Summary
This early-stage study aims to see how a new version of an experimental capsule (NPT 2042) is absorbed by the body compared to the original version. It involves a small group of healthy adults who will take single doses of each capsule. The goal is to gather basic information to help develop this drug for conditions like epilepsy and Alzheimer's disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Celerion
RECRUITINGLincoln, Nebraska, 68502, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.